Format

Send to

Choose Destination
Exp Biol Med (Maywood). 2016 Mar;241(6):620-35. doi: 10.1177/1535370215618462. Epub 2016 Jan 18.

Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.

Author information

1
Department of Sciences, University of Basilicata, 85100 Potenza, Italy paoloxriccio@gmail.com.
2
Department of Sciences, University of Basilicata, 85100 Potenza, Italy.
3
Department of Agricultural and Food Science, University of Naples "Federico II", 80055 Portici, Napoli, Italy.
4
Center for Applied Nutrition, 74010 Statte, Italy.
5
O.T.I. Officine Terapie Innovative S.r.l., 67061 Carsoli, Aquila, Italy.
6
Center for Multiple Sclerosis, Hospital ASL 4 "Madonna Delle Grazie", 75100 Matera, Italy.

Abstract

The aim of this work was to assess the influence of nutritional intervention on inflammatory status and wellness in people with multiple sclerosis. To this end, in a seven-month pilot study we investigated the effects of a calorie-restricted, semi-vegetarian diet and administration of vitamin D and other dietary supplements (fish oil, lipoic acid, omega-3 polyunsaturated fatty acids, resveratrol and multivitamin complex) in 33 patients with relapsing-remitting multiple sclerosis and 10 patients with primary-progressive multiple sclerosis. At 0/3/6 months, patients had neurological examination, filled questionnaires and underwent anthropometric measurements and biochemical analyses. Serum fatty acids and vitamin D levels were measured as markers of dietary compliance and nutritional efficacy of treatment, whereas serum gelatinase levels were analyzed as markers of inflammatory status. All patients had insufficient levels of vitamin D at baseline, but their values did not ameliorate following a weekly administration of 5000  IU, and rather decreased over time. Conversely, omega-3 polyunsaturated fatty acids increased already after three months, even under dietary restriction only. Co-treatment with interferon-beta in relapsing-remitting multiple sclerosis was irrelevant to vitamin D levels. After six months nutritional treatment, no significant changes in neurological signs were observed in any group. However, serum levels of the activated isoforms of gelatinase matrix metalloproteinase-9 decreased by 59% in primary-progressive multiple sclerosis and by 51% in relapsing-remitting multiple sclerosis patients under nutritional intervention, including dietary supplements. This study indicates that a healthy nutritional intervention is well accepted by people with multiple sclerosis and may ameliorate their physical and inflammatory status.

KEYWORDS:

Multiple sclerosis; complementary and alternative medicine; diet; gelatinases; inflammation; interferon-β; quality of life; vitamin D

PMID:
26785711
PMCID:
PMC4950325
DOI:
10.1177/1535370215618462
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center